by | PRNewswire Asia
HO CHI MINH CITY, Vietnam, Dec. 4, 2025 /PRNewswire/ — Lacàph Coffees of Việt Nam and BOLD84 Vietnamese Coffee, two brands under Collective Company Limited, are redefining what Vietnamese coffee stands for on the world stage. Both were recognized at...
by | PRNewswire Asia
OSAKA, Japan, Dec. 4, 2025 /PRNewswire/ — HiroPharmaConsulting (R) Co., Ltd. announced that it has received a patent for an innovative Good Pharmacovigilance Practice (GVP) Computerized System Validation (CSV) methodology designed to ensure the reliability of...
by | PRNewswire Asia
Global oncology society calls for abstract submissions for research that is shaping the future of cancer care in advance of annual Asia-Pacific meeting in Singapore SINGAPORE, Dec. 4, 2025 /PRNewswire/ — The American Society of Clinical Oncology (ASCO) today...
by | PRNewswire Asia
SEOUL, South Korea, Dec. 4, 2025 /PRNewswire/ — Iinnofashion is presenting a new K-beauty trend powered by its distinctive technological expertise. The recently launched "All-in-One Toner Mask Bubble Booster" stands out from conventional liquid toners...
by | PRNewswire Asia
Accomplished biotech and CRO leader brings 25+ years of global oncology drug development and operational excellence to propel Emerald’s continued growth. SINGAPORE, Dec. 3, 2025 /PRNewswire/ — Emerald Clinical Trials, a leading global clinical...
by | PRNewswire Asia
– XPOVIO® (selinexor) has received approvals for three indications in Hong Kong. These include its previous approval as the treatment for multiple myeloma (MM) when used together with dexamethasone (Xd), and its recent approvals as a monotherapy for relapsed...
